Disorganization of retinal inner layers (DRIL) is likely an important biomarker signaling visual deterioration in patients with diabetic macular ischemia (DMI), and overall causes for functional ...

For patients with diabetes, an automated binary diabetic macular ischemia (DMI) algorithm using optical coherence tomography angiography (OCTA) images predicts diabetic retinal disease progression ...

"Boehringer reports positive findings from diabetic macular ischemia trial" was originally created and published by Clinical Trials Arena, a GlobalData owned brand.

A doctor can perform laser treatment after RVO in areas with inadequate blood supply (retinal ischemia) and in areas where persistent leaking vessels appear. This treatment is usually recommended ...

If the blood vessels close off completely, it's called macular ischemia. This can lead to blurry vision with dark spots some people describe as “floaters.” If you reach this stage, there’s a ...

These changes are chronic. Since the retinal pigment epithelium lies anteriorly to the choroid, direct observation of ischemia or inflammation of the choroidal vessels is rarely possible in the ...

About BI 764524 BI 764524 is a humanized monoclonal anti-Sema3A antibody intended to re-vascularize ischemic areas and reduce leakage in the retina, offering the potential to address retinal non ...

Boehringer Ingelheim today presented positive data from the HORNBILL Phase I/IIa study of BI 764524, the first ever study exploring a potential treatment for people living with diabetic macular ...